<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38573841</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>13</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Surveillance To Track Progress Toward Polio Eradication - Worldwide, 2022-2023.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>285</EndPage><MedlinePgn>278-285</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7313a1</ELocationID><Abstract><AbstractText>The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication program. Since 1988, the number of polio cases caused by wild poliovirus (WPV) has declined by &gt;99.9%, and eradication of WPV serotypes 2 and 3 has been certified; only serotype 1 (WPV1) continues to circulate, and transmission remains endemic in Afghanistan and Pakistan. This surveillance update evaluated indicators from AFP surveillance, environmental surveillance for polioviruses, and Global Polio Laboratory Network performance data provided by 28 priority countries for the program during 2022-2023. No WPV1 cases have been detected outside of Afghanistan and Pakistan since August 2022, when an importation into Malawi and Mozambique resulted in an outbreak during 2021-2022. During 2022-2023, among 28 priority countries, 20 (71.4%) met national AFP surveillance indicator targets, and the number of environmental surveillance sites increased. However, low national rates of reported AFP cases in priority countries in 2023 might have resulted from surveillance reporting lags; substantial national and subnational AFP surveillance gaps persist. Maintaining high-quality surveillance is critical to achieving the goal of global polio eradication. Monitoring surveillance indicators is important to identifying gaps and guiding surveillance-strengthening activities, particularly in countries at high risk for poliovirus circulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kishore</LastName><ForeName>Nishant</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Krow-Lucal</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Diop</LastName><ForeName>Ousmane M</ForeName><Initials>OM</Initials></Author><Author ValidYN="Y"><LastName>Jorba</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Avagnan</LastName><ForeName>Tigran</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Grabovac</LastName><ForeName>Varja</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Kfutwah</LastName><ForeName>Anfumbom K W</ForeName><Initials>AKW</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Ticha</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Sangal</LastName><ForeName>Lucky</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Salmaan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wahdan</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tallis</LastName><ForeName>Graham F</ForeName><Initials>GF</Initials></Author><Author ValidYN="Y"><LastName>Kovacs</LastName><ForeName>Stephanie D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38573841</ArticleId><ArticleId IdType="pmc">PMC10997045</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7313a1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee SE, Greene SA, Burns CC, Tallis G, Wassilak SGF, Bolu O. Progress toward poliomyelitis eradication—worldwide, January 2021–March 2023. MMWR Morb Mortal Wkly Rep 2023;72:517–22. 10.15585/mmwr.mm7219a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7219a3</ArticleId><ArticleId IdType="pmc">PMC10208367</ArticleId><ArticleId IdType="pubmed">37167156</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjork A, Akbar IE, Chaudhury S, et al. Progress toward poliomyelitis eradication—Afghanistan, January 2022–June 2023. MMWR Morb Mortal Wkly Rep 2023;72:1020–6. 10.15585/mmwr.mm7238a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7238a1</ArticleId><ArticleId IdType="pmc">PMC10519716</ArticleId><ArticleId IdType="pubmed">37733636</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Baig S, Safdar RM, et al. Progress toward poliomyelitis eradication—Pakistan, January 2022–June 2023. MMWR Morb Mortal Wkly Rep 2023;72:880–5. 10.15585/mmwr.mm7233a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7233a1</ArticleId><ArticleId IdType="pmc">PMC10441828</ArticleId><ArticleId IdType="pubmed">37590173</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. Malawi. Geneva, Switzerland: Global Polio Eradication Initiative; 2023. https://polioeradication.org/where-we-work/malawi/</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Mozambique. Geneva, Switzerland: Global Polio Eradication Initiative; 2023. https://polioeradication.org/where-we-work/Mozambique/</Citation></Reference><Reference><Citation>Bigouette JP, Henderson E, Traoré MA, et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2021–December 2022. MMWR Morb Mortal Wkly Rep 2023;72:366–71. 10.15585/mmwr.mm7214a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7214a3</ArticleId><ArticleId IdType="pmc">PMC10078846</ArticleId><ArticleId IdType="pubmed">37022974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson AL, Diop OM, Jorba J, Gardner T, Snider CJ, Ahmed J. Surveillance to track progress toward polio eradication—worldwide, 2020–2021. MMWR Morb Mortal Wkly Rep 2022;71:538–44. 10.15585/mmwr.mm7115a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7115a2</ArticleId><ArticleId IdType="pmc">PMC9020859</ArticleId><ArticleId IdType="pubmed">35421079</ArticleId></ArticleIdList></Reference><Reference><Citation>Stehling-Ariza T, Wilkinson AL, Diop OM, et al. Surveillance to track progress toward poliomyelitis eradication—worldwide, 2021–2022. MMWR Morb Mortal Wkly Rep 2023;72:613–20. 10.15585/mmwr.mm7223a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7223a1</ArticleId><ArticleId IdType="pmc">PMC10328463</ArticleId><ArticleId IdType="pubmed">37289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop OM, Kew OM, de Gourville EM, Pallansch MA. The Global Polio Laboratory Network as a platform for the viral vaccine-preventable and emerging diseases laboratory networks. J Infect Dis 2017;216(Suppl_1):S299–307. 10.1093/infdis/jix092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix092</ArticleId><ArticleId IdType="pmc">PMC5853949</ArticleId><ArticleId IdType="pubmed">28838192</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>